These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11562096)

  • 1. An examination of the MMPI-2 Wiener-Harmon Subtle subscales for D and Hy: implications for parent scale and neurotic triad interpretation.
    Jones A
    J Pers Assess; 2001 Aug; 77(1):105-21. PubMed ID: 11562096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.
    Talarowska M; Zboralski K; Chamielec M; Gałecki P
    Psychiatr Danub; 2011 Dec; 23(4):347-54. PubMed ID: 22075735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of the MMPI-2 Subtle and Obvious scales with psychiatric inpatients.
    Boone D
    J Pers Assess; 1994 Apr; 62(2):346-51. PubMed ID: 8189342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative validity of the MMPI-2 Wiener-Harmon subtle-obvious scales in male prison inmates.
    Osberg TM; Harrigan P
    J Pers Assess; 1999 Feb; 72(1):36-48. PubMed ID: 10205869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Minnesota Multiphasic Personality Inventory (MMPI) Hysteria (Hy) scale: scoring bodily concern and psychological denial subscales in chronic back pain patients.
    Ornduff SR; Brennan AF; Barrett CL
    J Behav Med; 1988 Apr; 11(2):131-46. PubMed ID: 2971809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homogeneous scales for the neurotic triad of the MMPI.
    Beckwith JB; Hammond SB; Campbell IM
    J Pers Assess; 1983 Dec; 47(6):604-13. PubMed ID: 6663435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assessment of denial and physical complaints: the validity of the Hy scale and associated MMPI signs.
    McGrath RE; O'Malley WB
    J Clin Psychol; 1986 Sep; 42(5):754-60. PubMed ID: 3760208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correspondence of the MMPI-2 and MCMI-II in male substance abusers.
    Ward LC
    J Pers Assess; 1995 Apr; 64(2):390-3. PubMed ID: 7722864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the MCMI-III personality disorder and modifier indices with the MMPI-2 clinical and validity scales.
    Schoenberg MR; Dorr D; Morgan CD; Burke M
    J Pers Assess; 2004 Jun; 82(3):273-80. PubMed ID: 15151803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing dissimulation and denial on the MMPI in a sample of maximum security, male inmates.
    Walters GD
    J Pers Assess; 1988; 52(3):465-74. PubMed ID: 3210119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcissism and depression: MMPI-2 evidence for the continuum hypothesis in clinical samples.
    Watson PJ; Sawrie SM; Greene RL; Arredondo R
    J Pers Assess; 2002 Aug; 79(1):85-109. PubMed ID: 12227670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric characteristics of the MMPI-2 Cook-Medley Hostility scale.
    Han K; Weed NC; Calhoun RF; Butcher JN
    J Pers Assess; 1995 Dec; 65(3):567-85. PubMed ID: 16367714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new perspective on gender orientation measurement with the MMPI-2: development of the Masculine-Feminine Pathology Scale.
    McGrath RE; Sapareto E; Pogge DL
    J Pers Assess; 1998 Jun; 70(3):551-63. PubMed ID: 9760743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of Harris and Lingoes MMPI subscale descriptors in an outpatient sample.
    Wrobel TA
    J Pers Assess; 1992 Aug; 59(1):14-21. PubMed ID: 1512673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of MCMI DSM-III axis II constructs from MMPI scales and subscales.
    Zarrella KL; Schuerger JM; Ritz GH
    J Pers Assess; 1990; 55(1-2):195-201. PubMed ID: 2231239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overreport on the MCMI-III: concurrent validation with the MMPI-2 using a psychiatric inpatient sample.
    Morgan CD; Schoenberg MR; Dorr D; Burke MJ
    J Pers Assess; 2002 Apr; 78(2):288-300. PubMed ID: 12067194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle-obvious scales of the MMPI: indicators of profile validity in a psychiatric population.
    Brems C; Johnson ME
    J Pers Assess; 1991 Jun; 56(3):536-44. PubMed ID: 1865310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psychological assessment of depression: unipolars versus bipolars.
    Wetzler S; Khadivi A; Oppenheim S
    J Pers Assess; 1995 Dec; 65(3):557-66. PubMed ID: 8609588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An examination of three sets of MMPI-2 personality disorder scales.
    Jones A
    J Pers Disord; 2005 Aug; 19(4):370-85. PubMed ID: 16178680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of MMPI-A items in discriminating between normative and clinical samples.
    Archer RP; Handel RW; Lynch KD
    J Pers Assess; 2001 Dec; 77(3):420-35. PubMed ID: 11781030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.